What is it about?
Valproic acid (VPA) is an emerging option for behavioral control in critically ill patients. The purpose of this study was to describe its safety and efficacy for this indication. VPA therapy was associated with a reduction in agitation incidence and opioid utilization. Further studies in this patient population are warranted.
Featured Image
Read the Original
This page is a summary of: 596, Critical Care Medicine, December 2015, Wolters Kluwer Health,
DOI: 10.1097/01.ccm.0000474424.95007.e4.
You can read the full text:
Contributors
The following have contributed to this page
